Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Hormone replacement therapy improves contractile function and myonuclear organization of single muscle fibres from postmenopausal monozygotic female twin pairs.

Qaisar R, Renaud G, Hedstrom Y, Pöllänen E, Ronkainen P, Kaprio J, Alen M, Sipilä S, Artemenko K, Bergquist J, Kovanen V, Larsson L.

J Physiol. 2013 May 1;591(9):2333-44. doi: 10.1113/jphysiol.2012.250092. Epub 2013 Mar 4.


Hormone therapy is associated with better body composition and adipokine/glucose profiles: a study with monozygotic co-twin control design.

Ahtiainen M, Alen M, Pöllänen E, Pulkkinen S, Ronkainen PH, Kujala UM, Kaprio J, Sipilä S, Kovanen V.

Menopause. 2012 Dec;19(12):1329-35. doi: 10.1097/gme.0b013e31825a3344.


Muscle function in monozygotic female twin pairs discordant for hormone replacement therapy.

Finni T, Noorkoiv M, Pöllänen E, Ronkainen PH, Alén M, Kaprio J, Kovanen V, Sipilä S.

Muscle Nerve. 2011 Nov;44(5):769-75. doi: 10.1002/mus.22162.


Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women.

Ahtiainen M, Pöllänen E, Ronkainen PH, Alen M, Puolakka J, Kaprio J, Sipilä S, Kovanen V.

Age (Dordr). 2012 Oct;34(5):1249-60. Epub 2011 Aug 16.


Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and postmenopausal women.

Pöllänen E, Sipilä S, Alen M, Ronkainen PH, Ankarberg-Lindgren C, Puolakka J, Suominen H, Hämäläinen E, Turpeinen U, Konttinen YT, Kovanen V.

Aging Cell. 2011 Aug;10(4):650-60. doi: 10.1111/j.1474-9726.2011.00701.x. Epub 2011 Apr 12.


Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy.

Ronkainen PH, Pöllänen E, Alén M, Pitkänen R, Puolakka J, Kujala UM, Kaprio J, Sipilä S, Kovanen V.

Aging Cell. 2010 Dec;9(6):1098-110. doi: 10.1111/j.1474-9726.2010.00636.x. Epub 2010 Oct 29.


Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.

Pöllänen E, Ronkainen PH, Horttanainen M, Takala T, Puolakka J, Suominen H, Sipilä S, Kovanen V.

Growth Horm IGF Res. 2010 Oct;20(5):372-9. doi: 10.1016/j.ghir.2010.07.003. Epub 2010 Aug 17.


Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle.

Pöllänen E, Fey V, Törmäkangas T, Ronkainen PH, Taaffe DR, Takala T, Koskinen S, Cheng S, Puolakka J, Kujala UM, Suominen H, Sipilä S, Kovanen V.

Age (Dordr). 2010 Sep;32(3):347-63. doi: 10.1007/s11357-010-9140-1. Epub 2010 Apr 13.


Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs.

Ronkainen PH, Kovanen V, Alén M, Pöllänen E, Palonen EM, Ankarberg-Lindgren C, Hämäläinen E, Turpeinen U, Kujala UM, Puolakka J, Kaprio J, Sipilä S.

J Appl Physiol (1985). 2009 Jul;107(1):25-33. doi: 10.1152/japplphysiol.91518.2008. Epub 2009 Feb 26.


Combination of hormone replacement therapy and high physical activity is associated with differences in Achilles tendon size in monozygotic female twin pairs.

Finni T, Kovanen V, Ronkainen PH, Pöllänen E, Bashford GR, Kaprio J, Alén M, Kujala UM, Sipilä S.

J Appl Physiol (1985). 2009 Apr;106(4):1332-7. doi: 10.1152/japplphysiol.91439.2008. Epub 2009 Jan 22.


Catechol-o-methyltransferase gene polymorphism is associated with skeletal muscle properties in older women alone and together with physical activity.

Ronkainen PH, Pöllänen E, Törmäkangas T, Tiainen K, Koskenvuo M, Kaprio J, Rantanen T, Sipilä S, Kovanen V.

PLoS One. 2008 Mar 19;3(3):e1819. doi: 10.1371/journal.pone.0001819.


Muscular transcriptome in postmenopausal women with or without hormone replacement.

Pöllänen E, Ronkainen PH, Suominen H, Takala T, Koskinen S, Puolakka J, Sipilä S, Kovanen V.

Rejuvenation Res. 2007 Dec;10(4):485-500.


Supplemental Content

Loading ...
Support Center